Shopping Cart

No products in the cart.

BSI PD CEN ISO/TS 16775:2021 – TC:2022 Edition

$280.87

Tracked Changes. Packaging for terminally sterilized medical devices. Guidance on the application of ISO 11607-1 and ISO 11607-2

Published By Publication Date Number of Pages
BSI 2022 422
Guaranteed Safe Checkout
Categories: ,

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. Weโ€™re here to assist you 24/7.
Email:[email protected]

This document provides guidance for the application of the requirements contained in ISO 11607-1 and ISO 11607-2 . It does not add to, or otherwise change, the requirements of ISO 11607-1 and ISO 11607-2 . This is an informative document, not normative. It does not include requirements to be used as basis of regulatory inspection or certification assessment activities.

The guidance can be used to better understand the requirements of ISO 11607-1 and ISO 11607-2 and illustrates the variety of methods and approaches available for meeting the requirements of those International Standards. It is not required that this document be used to demonstrate conformity with them.

Guidance is given for evaluation, selection and use of packaging materials, preformed sterile barrier systems, sterile barrier systems and packaging systems. Guidance on validation requirements for forming, sealing and assembly processes is also given.

This document provides information for both healthcare facilities and the medical devices industry for terminally sterilized medical devices.

This document does not provide guidance for applications of packaging materials and systems after their opening. In the use of packaging for other purposes such as a โ€œsterile fieldโ€ or transport of contaminated items, other regulatory standards will apply.

PDF Catalog

PDF Pages PDF Title
1 30447897
269 A-30421958
270 National foreword
272 European foreword
277 Foreword
278 Introduction
279 1 Scope
2 Normative references
3 Terms and definitions
280 4 Guidance on Clauses 1-4 of ISO 11607โ€‘1:2019 and ISO 11607โ€‘2:2019
4.1 Scope (ISO 11607โ€‘1:2019, Clause 1 and ISO 11607โ€‘2:2019, Clause 1)
4.1.1 Intent
4.1.2 Guidance
281 4.2 Normative references (ISO 11607โ€‘1:2019, Clause 2 and ISO 11607โ€‘2:2019, Clause 2)
4.2.1 Intent
4.2.2 Guidance
282 4.3 Terms and definitions (ISO 11607โ€‘1:2019, Clause 3 and ISO 11607โ€‘2:2019, Clause 3)
4.3.1 Intent
4.3.2 Guidance
4.4 Quality and risk management (ISO 11607โ€‘1:2019, 4.1, 4.2 and ISO 11607โ€‘2:2019, 4.1, 4.2)
4.4.1 Intent
4.4.2 Guidance
284 4.5 Sampling (ISO 11607โ€‘1:2019, 4.3 and ISO 11607โ€‘2:2019, 4.3)
4.5.1 Intent
4.5.2 Guidance
285 4.6 Test methods (ISO 11607โ€‘1:2019, 4.4 and ISO 11607โ€‘2:2019, 4.4)
4.6.1 Intent
4.6.2 Guidance
287 4.7 Documentation (ISO 11607โ€‘1:2019, 4.5 and ISO 11607โ€‘2:2019, 4.5)
4.7.1 Intent
4.7.2 Guidance
288 5 Guidance on Clauses 5-11 of ISO 11607โ€‘1:2019
5.1 General requirements for materials, preformed sterile barrier systems and sterile barrier systems (ISO 11607โ€‘1:2019, 5.1.1 and 5.1.2)
5.1.1 Intent
5.1.2 Guidance
5.2 Conditions for production and handling (ISO 11607โ€‘1:2019, 5.1.3 and 5.1.4)
5.2.1 Intent
5.2.2 Guidance
289 5.3 Source, history and traceability of materials (ISO 11607โ€‘1:2019, 5.1.5)
5.3.1 Intent
5.3.2 Guidance
290 5.4 Properties to be evaluated (ISO 11607โ€‘1:2019, 5.1.6)
5.4.1 Intent
5.4.2 Guidance
5.5 General performance requirements for materials (ISO 11607โ€‘1:2019, 5.1.7 and 5.1.8)
5.5.1 Intent
291 5.5.2 Guidance
294 5.6 Additional requirements for sterile barrier systems and preformed sterile barrier systems (ISO 11607โ€‘1:2019, 5.1.9)
5.6.1 Intent
5.6.2 Guidance
295 5.7 Reusable sterile barrier systems (ISO 11607โ€‘1:2019, 5.1.10, 5.1.11 and 5.1.12)
5.7.1 Intent
5.7.2 Guidance
5.8 Microbial barrier properties (ISO 11607โ€‘1:2019, 5.2)
5.8.1 Intent
5.8.2 Guidance
296 5.9 Compatibility with the sterilization process (ISO 11607โ€‘1:2019, 5.3)
5.9.1 Intent
5.9.2 Guidance
297 5.10 Labelling system (ISO 11607โ€‘1:2019, 5.4)
5.10.1 Intent
5.10.2 Guidance
299 5.11 Storage and transport of materials and preformed sterile barrier systems (ISO 11607โ€‘1:2019, 5.5)
5.11.1 Intent
5.11.2 Guidance
300 5.12 Design and development (ISO 11607โ€‘1:2019, 6.1.1)
5.12.1 Intent
5.12.2 Guidance
301 5.13 Aseptic presentation (ISO 11607โ€‘1:2019, 6.1.2)
5.13.1 Intent
5.13.2 Guidance
302 5.14 Physical protection (ISO 11607โ€‘1:2019, 6.1.3 and 6.1.4)
5.14.1 Intent
5.14.2 Guidance
303 5.15 Sterilization compatibility (ISO 11607โ€‘1:2019, 6.1.5)
5.15.1 Intent
5.15.2 Guidance
5.16 Maintenance of Sterility (ISO 11607โ€‘1:2019, 6.1.6 and 6.1.7)
5.16.1 Intent
5.16.2 Guidance
304 5.17 Requirements for multi-layer packaging (ISO 11607โ€‘1:2019, 6.1.8)
5.17.1 Intent
5.17.2 Guidance
305 5.18 Packaging families (ISO 11607โ€‘1:2019, 6.1.9)
5.18.1 Intent
5.18.2 Guidance
306 5.19 Design process (ISO 11607โ€‘1:2019, 6.2.1)
5.19.1 Intent
307 5.19.2 Guidance
5.20 Design inputs (ISO 11607โ€‘1:2019, 6.2.2 and 6.2.3)
5.20.1 Intent
5.20.2 Guidance
309 5.21 Sterile fluid path (ISO 11607โ€‘1:2019, 6.2.4, 6.2.5)
5.21.1 Intent
5.21.2 Guidance
310 5.22 Usability evaluation for aseptic presentation (ISO 11607โ€‘1:2019, 7.1, 7.2 and 7.3)
5.22.1 Intent
5.22.2 Guidance
311 5.23 Leveraging usability evaluations (ISO 11607โ€‘1:2019, 7.4)
5.23.1 Intent
5.23.2 Guidance
5.24 Usability evaluation failures (ISO 11607โ€‘1:2019, 7.5)
5.24.1 Intent
5.24.2 Guidance
312 5.24.3 Guidance on formative and summative studies
313 5.25 Packaging system performance and stability (ISO 11607โ€‘1:2019, 8.1)
5.25.1 Intent
5.25.2 Guidance
315 5.26 Packaging system performance testing (ISO 11607โ€‘1:2019, 8.2)
5.26.1 Intent
5.26.2 Guidance
316 5.27 Stability testing (ISO 11607โ€‘1:2019, 8.3)
5.27.1 Intent
5.27.2 Guidance
318 5.28 Packaging system validation and changes (ISO 11607โ€‘1:2019, 9.1)
5.28.1 Intent
5.28.2 Guidance
5.29 Change control (ISO 11607โ€‘1:2019, 9.2)
5.29.1 Intent
5.29.2 Guidance
5.30 Revalidations (ISO 11607โ€‘1:2019, 9.3, 9.4, and 9.5)
5.30.1 Intent
5.30.2 Guidance
319 5.31 Inspection immediately prior to aseptic presentation (ISO 11607โ€‘1:2019, Clause 10)
5.31.1 Intent
5.31.2 Guidance
5.32 Information to be provided (ISO 11607โ€‘1:2019, Clause 11)
5.32.1 Intent
5.32.2 Guidance
320 6 Guidance on Clauses 5-8 of ISO 11607โ€‘2:2019
6.1 General Clauses 1-4 of ISO 11607โ€‘2:2019
6.2 Validation of packaging processes โ€“ general requirements (ISO 11607โ€‘2:2019, 5.1.1 and 5.1.2)
6.2.1 Intent
6.2.2 Guidance
321 6.3 Process specification (ISO 11607โ€‘2:2019, 5.1.3)
6.3.1 Intent
6.3.2 Guidance
6.4 Process validation of packaging families (ISO 11607โ€‘2:2019, 5.1.4)
6.4.1 Intent
6.4.2 Guidance
322 6.5 Installation qualification (ISO 11607โ€‘2:2019, 5.2)
6.5.1 Intent
323 6.5.2 Guidance
6.6 Operational qualification (ISO 11607โ€‘2:2019, 5.3)
6.6.1 Intent
324 6.6.2 Guidance
6.7 Performance qualification (ISO 11607โ€‘2:2019, 5.4)
6.7.1 Intent
6.7.2 Guidance
325 6.8 Formal approval of the process validation (ISO 11607โ€‘2:2019, 5.5)
6.8.1 Intent
6.8.2 Guidance
326 6.9 Process control and monitoring (ISO 11607โ€‘2:2019, 5.6)
6.9.1 Intent
6.9.2 Guidance
6.10 Process changes and revalidation (ISO 11607โ€‘2:2019, 5.7)
6.10.1 Intent
6.10.2 Guidance
327 6.11 Assembly (ISO 11607โ€‘2:2019, Clause 6)
6.11.1 Intent
6.11.2 Guidance
329 6.12 Use of reusable sterile barrier systems (ISO 11607โ€‘2:2019, Clause 7)
6.12.1 Intent
6.12.2 Guidance
6.13 Sterile fluid path packaging (ISO 11607โ€‘2:2019, Clause 8)
6.13.1 Intent
6.13.2 Guidance
330 Bibliography
335 Annex A (informative) Design and development for packaging systems โ€“ guidance for industry
343 Annex B (informative) Guidance on the application of the ISO 11607 series in healthcare facilities
374 Annex C (informative) Risk analysis tools โ€” Guidance for industry and healthcare facilities
376 Annex D (informative) Considerations for sampling plans โ€“ Guidance for healthcare facilities
378 Annex E (informative) Guidance on establishing process parameters โ€“ guidance for industry
384 Annex F (informative) Sterilization considerations โ€“ Guidance for industry and healthcare facilities
391 Annex G (informative) Use of contract packagers โ€“ Guidance for industry and healthcare facilities
392 Annex H (informative) Example of a handling, distribution and storage checklist โ€“ Guidance for healthcare facilities for selecting a sterile barrier system
394 Annex I (informative) Investigating failure โ€“ Guidance for industry and healthcare facilities
398 Annex J (informative) Validation summary โ€“ Guidance for healthcare facilities
400 Annex K (informative) Validation for wrapping process โ€” Guidance for healthcare facilities
406 Annex L (informative) Validation for reusable container process โ€“ Guidance for healthcare facilities
412 Annex M (informative) Validation for heat sealing process for preformed sterile barrier systems (PSBS) โ€“ Guidance for healthcare facilities
BSI PD CEN ISO/TS 16775:2021 - TC
$280.87